<?xml version="1.0" encoding="UTF-8"?>
<p>Both SARS-CoV and SARS-CoV-2 enter human cells exploiting the link with membrane-bound angiotensin converting enzyme II (ACE2) protein, which is widely expressed in many cells across the body, including type II alveolar cells (AT2), upper airways cells, endothelial cells, myocardial cells, proximal tubule cells of the kidney, ileum and esophagus epithelial cells, and bladder urothelial cells [
 <xref rid="B13-vaccines-08-00224" ref-type="bibr">13</xref>,
 <xref rid="B14-vaccines-08-00224" ref-type="bibr">14</xref>,
 <xref rid="B15-vaccines-08-00224" ref-type="bibr">15</xref>,
 <xref rid="B16-vaccines-08-00224" ref-type="bibr">16</xref>,
 <xref rid="B17-vaccines-08-00224" ref-type="bibr">17</xref>].
</p>
